COVID-19. COVID-19
Conditions
Interventions
Intervention 1: Intervention group: Corona treatment (1- Remedicivir: 200 mg on the first day and then 100 mg daily for 4 days
2- Dexamethasone: 8 mg daily
3- Enoxaparin 40 mg every 12 hours or Heparin 5000 units every 8 hours) + Padzahr tablets (made by NIAK with license number 0385-94-S): 2 pieces, after meals (three times a day). Intervention 2: Contr
3- Enoxaparin 40 mg every 12 hours or Heparin 5000 units every 8 hours).
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Probable diagnosis of COVID-19 based on national Iranian protocol
Exclusion criteria
Exclusion criteria: Late 5 days from the onset of symptoms Existence of comorbidity Pregnancy and lactation history of Allergy Complicated with bacterial infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever reduction time. Timepoint: Time to start reducing fever after the intervention. Method of measurement: hour.;Fever intensity. Timepoint: All days of hospitalization. Method of measurement: C.;Blood oxygen saturation. Timepoint: All days after the intervention. Method of measurement: Pulse oximetry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospital stay. Timepoint: Patient discharge time. Method of measurement: day. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAssie Jokar
Mazandaran University of Medical Sciences
Outcome results
None listed